NCT03228667 2026-01-14
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
Phase 2 Active not recruiting
ImmunityBio, Inc.
Tesaro, Inc.
Trishula Therapeutics, Inc.
The Netherlands Cancer Institute
IGM Biosciences, Inc.
Karyopharm Therapeutics Inc